Gadoxetic acid–enhanced magnetic resonance imaging to predict paritaprevir-induced hyperbilirubinemia during treatment of hepatitis C

BACKGROUND: Paritaprevir inhibits organic anion–transporting polypeptide (OATP)1B1 and OATP1B3, which transport bilirubin. Hyperbilirubinemia is an adverse event reported during hepatitis C treatment. Gadoxetic acid is also transported by OATP1B1/1B3. We evaluated whether the enhancement effect in g...

Descripción completa

Detalles Bibliográficos
Autores principales: Okubo, Hironao, Ando, Hitoshi, Sorin, Yushi, Nakadera, Eisuke, Fukada, Hiroo, Morishige, Junichi, Miyazaki, Akihisa, Ikejima, Kenichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5927452/
https://www.ncbi.nlm.nih.gov/pubmed/29709031
http://dx.doi.org/10.1371/journal.pone.0196747

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5927452/
https://www.ncbi.nlm.nih.gov/pubmed/29709031
http://dx.doi.org/10.1371/journal.pone.0196747

Ejemplares similares